Suppr超能文献

肥胖导致心力衰竭的机制。

Mechanisms of heart failure in obesity.

作者信息

Ebong Imo A, Goff David C, Rodriguez Carlos J, Chen Haiying, Bertoni Alain G

机构信息

Department of Medicine, University of Southern California, Los Angeles, CA, United States.

Colorado School of Public Health, Aurora, CO, United States.

出版信息

Obes Res Clin Pract. 2014 Nov-Dec;8(6):e540-8. doi: 10.1016/j.orcp.2013.12.005. Epub 2014 Jan 6.

Abstract

Heart failure is a leading cause of morbidity and mortality and its prevalence continues to rise. Because obesity has been linked with heart failure, the increasing prevalence of obesity may presage further rise in heart failure in the future. Obesity-related factors are estimated to cause 11% of heart failure cases in men and 14% in women. Obesity may result in heart failure by inducing haemodynamic and myocardial changes that lead to cardiac dysfunction, or due to an increased predisposition to other heart failure risk factors. Direct cardiac lipotoxicity has been described where lipid accumulation in the heart results in cardiac dysfunction inexplicable of other heart failure risk factors. In this overview, we discussed various pathophysiological mechanisms that could lead to heart failure in obesity, including the molecular mechanisms underlying cardiac lipotoxicity. We defined the obesity paradox and enumerated various premises for the paradoxical associations observed in the relationship between obesity and heart failure.

摘要

心力衰竭是发病和死亡的主要原因,其患病率持续上升。由于肥胖与心力衰竭有关,肥胖患病率的上升可能预示着未来心力衰竭的进一步增加。据估计,肥胖相关因素导致男性心力衰竭病例的11%,女性为14%。肥胖可能通过引起导致心脏功能障碍的血流动力学和心肌变化,或由于对其他心力衰竭危险因素的易感性增加而导致心力衰竭。已经描述了直接心脏脂毒性,即心脏中的脂质积累导致无法用其他心力衰竭危险因素解释的心脏功能障碍。在本综述中,我们讨论了肥胖中可能导致心力衰竭的各种病理生理机制,包括心脏脂毒性的分子机制。我们定义了肥胖悖论,并列举了肥胖与心力衰竭关系中观察到的悖论关联的各种前提。

相似文献

1
Mechanisms of heart failure in obesity.
Obes Res Clin Pract. 2014 Nov-Dec;8(6):e540-8. doi: 10.1016/j.orcp.2013.12.005. Epub 2014 Jan 6.
2
Update on Obesity and Obesity Paradox in Heart Failure.
Prog Cardiovasc Dis. 2016 Jan-Feb;58(4):393-400. doi: 10.1016/j.pcad.2015.12.003. Epub 2015 Dec 23.
3
[Obesity and the prognosis of heart failure: the obesity paradox, myth or reality?].
Bull Acad Natl Med. 2014 Jan;198(1):61-9; discussion 69-70.
4
The Impact of Obesity in Heart Failure.
Heart Fail Clin. 2020 Jan;16(1):71-80. doi: 10.1016/j.hfc.2019.08.008.
5
Obesity and the risk of heart failure.
N Engl J Med. 2002 Aug 1;347(5):305-13. doi: 10.1056/NEJMoa020245.
6
[Obesity and cardiac failure].
Arch Mal Coeur Vaiss. 2005 Jan;98(1):39-45.
7
[Obesity and cardiovascular disease: expected and unexpected relationship].
Monaldi Arch Chest Dis. 2005 Mar;64(1):38-41. doi: 10.4081/monaldi.2005.610.
8
Insulin resistance and heart failure.
Curr Heart Fail Rep. 2009 Jun;6(2):89-94. doi: 10.1007/s11897-009-0014-8.
9
Cardiac Effects of Obesity: PATHOPHYSIOLOGIC, CLINICAL, AND PROGNOSTIC CONSEQUENCES-A REVIEW.
J Cardiopulm Rehabil Prev. 2016 Jan-Feb;36(1):1-11. doi: 10.1097/HCR.0000000000000147.
10
Body habitus in heart failure: understanding the mechanisms and clinical significance of the obesity paradox.
Future Cardiol. 2016 Nov;12(6):639-653. doi: 10.2217/fca-2016-0029. Epub 2016 Oct 20.

引用本文的文献

3
Heart failure with preserved ejection fraction and obesity: emerging metabolic therapeutic strategies.
Diabetol Metab Syndr. 2025 Aug 18;17(1):336. doi: 10.1186/s13098-025-01917-z.
7
The Obesity Paradox of Cardiovascular Outcomes in Patients with Diabetes Mellitus.
Curr Diab Rep. 2025 Jun 7;25(1):35. doi: 10.1007/s11892-025-01592-4.
10
Obesity and heart failure with preserved ejection fraction: focus on new drugs and future direction in medical treatment.
Korean J Intern Med. 2025 May;40(3):357-370. doi: 10.3904/kjim.2024.387. Epub 2025 Apr 30.

本文引用的文献

1
Sphingolipid metabolism and obesity-induced inflammation.
Front Endocrinol (Lausanne). 2013 Jun 4;4:67. doi: 10.3389/fendo.2013.00067. eCollection 2013.
2
Association of lipids with incident heart failure among adults with and without diabetes mellitus: Multiethnic Study of Atherosclerosis.
Circ Heart Fail. 2013 May;6(3):371-8. doi: 10.1161/CIRCHEARTFAILURE.112.000093. Epub 2013 Mar 25.
3
Cardiac lipotoxicity: molecular pathways and therapeutic implications.
Curr Heart Fail Rep. 2013 Jun;10(2):109-21. doi: 10.1007/s11897-013-0133-0.
4
The relationship between measures of obesity and incident heart failure: the multi-ethnic study of atherosclerosis.
Obesity (Silver Spring). 2013 Sep;21(9):1915-22. doi: 10.1002/oby.20298. Epub 2013 May 23.
5
Lipotoxicity contributes to endothelial dysfunction: a focus on the contribution from ceramide.
Rev Endocr Metab Disord. 2013 Mar;14(1):59-68. doi: 10.1007/s11154-012-9235-3.
6
Adipose tissue biology and cardiomyopathy: translational implications.
Circ Res. 2012 Dec 7;111(12):1565-77. doi: 10.1161/CIRCRESAHA.111.262493.
7
Mechanisms of cardiac dysfunction in obstructive sleep apnea.
Nat Rev Cardiol. 2012 Dec;9(12):679-88. doi: 10.1038/nrcardio.2012.141. Epub 2012 Sep 25.
8
Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure.
Heart Fail Clin. 2012 Oct;8(4):633-41. doi: 10.1016/j.hfc.2012.06.003. Epub 2012 Aug 10.
9
Role of lipotoxicity in endothelial dysfunction.
Heart Fail Clin. 2012 Oct;8(4):589-607. doi: 10.1016/j.hfc.2012.06.012. Epub 2012 Aug 10.
10
Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions.
Curr Cardiol Rev. 2012 Nov;8(4):253-64. doi: 10.2174/157340312803760749.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验